Internal Medicine, Gastroenterology · Merrick, NY
NPI
1568435931
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
131 Merrick Rd, Suite 1
Merrick, NY, 11566
Phone (516) 223-1515
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
800 services
Medicare patients, 2024
311
Average age 73
Drug cost, 2024
$1.6M
1,009 prescriptions
Company payments, 2025
$62K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven D Rubin was code 99214 (office e&m - established), 385 times for 240 patients. In total Steven D Rubin billed 800 services in 14 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 385 | 240 | $98.32 | $38K |
| 43239 Upper GI Endoscopy | Facility | 133 | 131 | $63.86 | $8,493 |
| 99204 Office E&M - New | Office | 80 | 80 | $123.61 | $9,889 |
| 45380 Lower GI Endoscopy - Other | Facility | 65 | 65 | $140.44 | $9,129 |
| 43251 Upper GI Endoscopy | Facility | 64 | 64 | $157.68 | $10K |
| 82270 Immunoassay | Office | 47 | 47 | $4.29 | $202 |
By year: 2022 $147K for 2,728 services; 2023 $104K for 958 services; 2024 $80K for 800 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82270 Immunoassay | 47 | 47 | $4.29 | $202 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven D Rubin prescribed most often to Medicare patients was Omeprazole, with 322 prescriptions and refills. In total Steven D Rubin wrote 1,009 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 322 | 811 | 141 | $3,646 |
| Creon Lipase/Protease/Amylase | 116 | 235 | 46 | $658K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 78 | 78 | 78 | $4,872 |
| Pantoprazole Sodium Generic | 59 | 163 | 25 | $1,133 |
| Zenpep Lipase/Protease/Amylase | 56 | 106 | 21 | $442K |
| Mesalamine Generic | 34 | 55 | Under 11 | $36K |
| Amitriptyline Hcl Generic | 34 | 87 | Under 11 | $491 |
| Voquezna Vonoprazan Fumarate | 33 | 48 | 15 | $29K |
| Linzess Linaclotide | 30 | 74 | 14 | $45K |
| Pancreaze Lipase/Protease/Amylase | 23 | 32 | 13 | $73K |
| Mercaptopurine Generic | 16 | 24 | Under 11 | $3,024 |
| Metronidazole Generic | 16 | 16 | Under 11 | $653 |
| Lubiprostone Generic | 16 | 40 | Under 11 | $7,282 |
| Dicyclomine Hcl Generic | 13 | 27 | Under 11 | $207 |
| Lansoprazole Generic | 13 | 39 | Under 11 | $360 |
Brand drugs: 338 claims; generic drugs: 671 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven D Rubin $62K ($62K in general payments such as food, travel and fees) from 15 companies. The largest payer was Ardelyx, Inc. with $21K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.